GSA Capital Partners’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-62,671
Closed -$1.12M 1672
2025
Q3
$1.12M Sell
62,671
-134,266
-68% -$1.95M 0.09% 332
2025
Q2
$2.14M Buy
196,937
+98,718
+101% +$1.29M 0.15% 116
2025
Q1
$1.82M Buy
98,219
+84,186
+600% +$1.52M 0.16% 91
2024
Q4
$231K Buy
+14,033
New +$199K 0.02% 1342
2024
Q1
Sell
-62,583
Closed -$427K 1599
2023
Q4
$427K Buy
+62,583
New +$348K 0.04% 898
2022
Q2
Sell
-17,398
Closed -$138K 1397
2022
Q1
$138K Buy
+17,398
New +$150K 0.02% 1245
2021
Q3
Sell
-14,782
Closed -$319K 1410
2021
Q2
$319K Buy
+14,782
New +$299K 0.04% 909

Other funds holding AXGN

GSA Capital Partners's AXGN Position: Q4 2025 in Review

GSA Capital Partners sold out of Axogen (AXGN) in Q4 2025, closing a stake of 62,671 shares — an estimated $1.12M sold.

GSA Capital Partners first reported a position in AXGN in Q2 2021 and held it in 7 quarters. The position peaked at $2.14M in Q2 2025. 208 funds tracked by Wall St. Rank hold AXGN as of Q4 2025.

  • GSA Capital Partners reported no remaining Axogen position as of Q4 2025 after selling out during the quarter.
  • GSA Capital Partners sold 62,671 Axogen shares in Q4 2025, an estimated $1.12M.
  • GSA Capital Partners first reported a position in Axogen in Q2 2021 and held it in 7 quarters.
  • GSA Capital Partners's Axogen position peaked at $2.14M in Q2 2025.
  • 208 funds tracked by Wall St. Rank held Axogen as of Q4 2025.

Based on GSA Capital Partners's 13F filing for Q4 2025, filed 6 Feb 2026.